Pharmafile Logo
Pharmafocus logo
Advanced Search

Takeda appoints Kiyohiko Tamura

pharmafile | May 25, 2010 | Appointment | Sales and Marketing |  Takeda, appointment, sales and marketing 

Japanese pharma company Takeda has appointed Kiyohiko Tamura general manager of its newly established Office of the President & CEO.

Tamura was previously director of division planning in the marketing, planning and administration department within Takeda’s pharmaceutical marketing division.

Tamura’s appointment and the new office’s establishment take effect from 1 June.

Advertisement

Related Content

Von Willebrand disease – increasing awareness and access to vital care

Pharmafile talks to Anthea Cherednichenko, Vice President Franchise Head Haematology and Transplant at Takeda about …

Combination treatments: Takeda’s Implementation Framework and the broader landscape

Pharmafile talks to Emma Roffe, Oncology Country Head (UK & Ireland) about the combination treatment …

Takeda presents positive results from trial of chronic kidney disease treatment

Takeda Pharmaceuticals has announced positive results from a proof-of-concept study of mezagitamab (TAK-079) to treat …

The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026